These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31741311

  • 1. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review.
    Pratt C, Campbell MD.
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):834-839. PubMed ID: 31741311
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
    Konstantis G, Efstathiou S, Pourzitaki C, Kitsikidou E, Germanidis G, Chourdakis M.
    Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J.
    Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
    [Abstract] [Full Text] [Related]

  • 4. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A.
    J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V, Gschossmann J, Layer P.
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC.
    Gastroenterology; 2023 Nov 14; 165(5):1206-1218. PubMed ID: 37541528
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.
    Am J Gastroenterol; 2006 Jul 14; 101(7):1581-90. PubMed ID: 16863564
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhang WX, Shi LB, Zhou MS, Wu J, Shi HY.
    J Med Microbiol; 2023 Sep 14; 72(9):. PubMed ID: 37772692
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review.
    Müller A, Franke H, Resch KL, Fryer G.
    J Am Osteopath Assoc; 2014 Jun 14; 114(6):470-9. PubMed ID: 24917634
    [Abstract] [Full Text] [Related]

  • 16. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 14; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM.
    Gut; 2010 Mar 14; 59(3):325-32. PubMed ID: 19091823
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome.
    Ruiz-Sánchez C, Escudero-López B, Fernández-Pachón MS.
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan 14; 71(1):19-30. PubMed ID: 38331656
    [Abstract] [Full Text] [Related]

  • 19. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS.
    Am J Gastroenterol; 2009 Apr 14; 104(4):1033-49; quiz 1050. PubMed ID: 19277023
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T.
    Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.